Radiation-induced ATM and ERK signaling in DSB repair
Radiation-induced ATM and ERK signaling in DSB repair
批准号:
8073827
负责人:
KRISTOFFER Carl VALERIE
金额:
$2.1万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-15 至 2010-08-31
关键词:
ATM Signaling PathwayATM activationAffectBRCA1 geneBiological AssayBypassCDC25A geneCell CycleCell Cycle CheckpointCell SurvivalCell physiologyCellsCellular StressCessation of lifeCritical PathwaysDNA DamageDNA Double Strand BreakDNA RepairDominant-Negative MutationDouble Strand Break RepairDsRedEpidermal Growth Factor ReceptorEquilibriumFeedbackFlow CytometryFluorescenceGene ExpressionGenomicsGliomaGrowthGrowth FactorGrowth Factor ReceptorsHandHomeostasisHumanHuman EngineeringIonizing radiationKineticsLinkMEKsMalignant NeoplasmsMammalian CellMeasuresMitogensMonitorNonhomologous DNA End JoiningNuclearOxidative StressPI3K/AKTParticipantPathway interactionsPhosphorylationProcessProliferatingProtein Phosphatase 2A Regulatory Subunit PR53ProteinsProto-Oncogene Proteins c-aktRadiationReceptor SignalingRegulationReportingRoleSerineSignal PathwaySignal TransductionSmall Interfering RNAStressSystemartemisbasebiological adaptation to stresscancer therapycell growthdesignendodeoxyribonuclease SceIhomologous recombinationimprovedinhibitor/antagonistinterestneoplastic cellnovelnucleasepublic health relevancerecombinational repairrepairedresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): ATM regulates many cellular processes including DNA damage responses and DNA double-strand break (DSB) repair in addition to responses involving oxidative stress and cell growth. Many of the processes ATM are associated with that are triggered by radiation have been described and characterized. However, the mechanisms involved in ATM's ability to balance growth and assess DNA damage (and other stresses) and help the cell decide between survival and death are relatively unknown. We have recently reported on the interesting observation that in response to radiation, ATM and prosurvival MEK/ERK signaling forms a feedback loop that regulates homologous recombination repair - ATM regulates ERK phosphorylation (and thus activation) whereas MEK/ERK is required for phosphorylation of ATM at serine-1981. Neither mechanism is presently known. Herein, we propose to determine the mechanisms of both these processes as well as the role of ATM and MEK/ERK signaling in regulating non-homologous end-joining (NHEJ), and, in particular, whether ATM and MEK/ERK signaling control DNA repair fidelity in this system. We will focus our studies on finding possible links between growth factor receptor and PI3K/AKT survival signaling and the ability to modulate the quality of NHEJ. A better understanding of these processes is important since there is little information available regarding the cell's ability to balance cellular growth with stress responses in cancer, in particular how it relates to DSB repair. This information might be utilized for improving cancer therapy. PUBLIC HEALTH RELEVANCE: There is little information available regarding the cell's ability to balance cellular growth with stress responses in cancer, in particular how it relates to DNA repair. The dynamic interaction between growth and stress that is controlled by ATM is important and might be utilized for improving cancer therapy.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Replacing amino acids in translation: expanding chemical diversity with non-natural variants.
在翻译中取代氨基酸:用非天然变体扩大化学多样性。
DOI:
10.1016/j.ymeth.2012.03.015
发表时间:
2013
期刊:
Methods (San Diego, Calif.)
影响因子:
--
作者:
[White,ERailey, Reed,TimothyM, Ma,Zhong, Hartman,MatthewCT]
通讯作者:
Hartman,MatthewCT
Glioblastoma radioimmunotherapy
-
批准号:10057915
-
项目类别:
-
资助金额:$23.29万
-
财政年份:2020
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
Glioblastoma radioimmunotherapy
-
批准号:10231261
-
项目类别:
-
资助金额:$19.41万
-
财政年份:2020
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
Novel, orally available ATM inhibitor for glioma conformal radiosensitization
-
批准号:9184543
-
项目类别:
-
资助金额:$16.58万
-
财政年份:2015
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
Targeting invasion and DNA DSB repair in glioma with a multi-pronged approach.
-
批准号:8206662
-
项目类别:
-
资助金额:$19.51万
-
财政年份:2010
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
Targeting invasion and DNA DSB repair in glioma with a multi-pronged approach.
-
批准号:8059203
-
项目类别:
-
资助金额:$16.26万
-
财政年份:2010
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
ATM as target for malignant glioma radiosensitization.
-
批准号:7748582
-
项目类别:
-
资助金额:$32.31万
-
财政年份:2009
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
ATM as target for malignant glioma radiosensitization.
-
批准号:8327481
-
项目类别:
-
资助金额:$3.71万
-
财政年份:2009
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
Radiation-induced ATM and ERK signaling in DSB repair
-
批准号:7448331
-
项目类别:
-
资助金额:$22.35万
-
财政年份:2009
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
ATM as target for malignant glioma radiosensitization.
-
批准号:8308640
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2009
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
ATM as target for malignant glioma radiosensitization.
-
批准号:8517834
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2009
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
ATM as target for malignant glioma radiosensitization.
-
批准号:8112696
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2009
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
ATM as target for malignant glioma radiosensitization.
-
批准号:8466880
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2009
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
Radiation-induced ATM and ERK signaling in DSB repair
-
批准号:7845000
-
项目类别:
-
资助金额:$18.63万
-
财政年份:2009
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
Virus Vector Shared Resource
-
批准号:7698828
-
项目类别:
-
资助金额:$1.52万
-
财政年份:2008
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
GAMMACELL 40 137 CS IRRADIATOR
-
批准号:7335177
-
项目类别:
-
资助金额:$36.1万
-
财政年份:2006
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
Gammacell 40 137 Cs Irradiator
-
批准号:7047254
-
项目类别:
-
资助金额:$36.1万
-
财政年份:2006
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
CORE--ADENOVIRUS FACILITY
-
批准号:6475014
-
项目类别:
-
资助金额:$18.41万
-
财政年份:2001
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
GENETIC MANIPULATION OF TUMOR RADIORESISTANCE
-
批准号:6475011
-
项目类别:
-
资助金额:$18.41万
-
财政年份:2001
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
CORE--ADENOVIRUS FACILITY
-
批准号:6336440
-
项目类别:
-
资助金额:$10.06万
-
财政年份:2000
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
GENETIC MANIPULATION OF TUMOR RADIORESISTANCE
-
批准号:6336437
-
项目类别:
-
资助金额:$10.06万
-
财政年份:2000
-
负责人:KRISTOFFER Carl VALERIE
-
依托单位:
海外基金